Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.

Taylor KH, Pena-Hernandez KE, Davis JW, Arthur GL, Duff DJ, Shi H, Rahmatpanah FB, Sjahputera O, Caldwell CW.

Cancer Res. 2007 Mar 15;67(6):2617-25.

2.

ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis.

Lind GE, Kleivi K, Meling GI, Teixeira MR, Thiis-Evensen E, Rognum TO, Lothe RA.

Cell Oncol. 2006;28(5-6):259-72.

3.

Epigenetic inactivation of the HOXA gene cluster in breast cancer.

Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW.

Cancer Res. 2006 Nov 15;66(22):10664-70. Epub 2006 Nov 6.

4.

Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.

Hiraga J, Kinoshita T, Ohno T, Mori N, Ohashi H, Fukami S, Noda A, Ichikawa A, Naoe T.

Int J Hematol. 2006 Oct;84(3):248-55.

PMID:
17050200
5.

MMASS: an optimized array-based method for assessing CpG island methylation.

Ibrahim AE, Thorne NP, Baird K, Barbosa-Morais NL, Tavaré S, Collins VP, Wyllie AH, Arends MJ, Brenton JD.

Nucleic Acids Res. 2006;34(20):e136. Epub 2006 Oct 13.

6.

Hypermethylation of the GATA gene family in esophageal cancer.

Guo M, House MG, Akiyama Y, Qi Y, Capagna D, Harmon J, Baylin SB, Brock MV, Herman JG.

Int J Cancer. 2006 Nov 1;119(9):2078-83.

7.

Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.

Shi H, Guo J, Duff DJ, Rahmatpanah F, Chitima-Matsiga R, Al-Kuhlani M, Taylor KH, Sjahputera O, Andreski M, Wooldridge JE, Caldwell CW.

Carcinogenesis. 2007 Jan;28(1):60-70. Epub 2006 Jun 14.

PMID:
16774933
8.

Comparisons of PCR-based genome amplification systems using CpG island microarrays.

Pike BL, Groshen S, Hsu YH, Shai RM, Wang X, Holtan N, Futscher BW, Hacia JG.

Hum Mutat. 2006 Jun;27(6):589-96.

PMID:
16652338
9.

Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.

Frigola J, Song J, Stirzaker C, Hinshelwood RA, Peinado MA, Clark SJ.

Nat Genet. 2006 May;38(5):540-9. Epub 2006 Apr 23.

PMID:
16642018
10.

Evidence for an instructive mechanism of de novo methylation in cancer cells.

Keshet I, Schlesinger Y, Farkash S, Rand E, Hecht M, Segal E, Pikarski E, Young RA, Niveleau A, Cedar H, Simon I.

Nat Genet. 2006 Feb;38(2):149-53.

PMID:
16444255
11.

Prognostic biomarkers in diffuse large B-cell lymphoma.

Lossos IS, Morgensztern D.

J Clin Oncol. 2006 Feb 20;24(6):995-1007. Epub 2006 Jan 17. Review.

PMID:
16418498
12.

Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group.

Shiozawa E, Takimoto M, Makino R, Adachi D, Saito B, Yamochi-Onizuka T, Yamochi T, Shimozuma J, Maeda T, Kohno Y, Kawakami K, Nakamaki T, Tomoyasu S, Shiokawa A, Ota H.

Leuk Res. 2006 Jul;30(7):859-67. Epub 2006 Jan 9.

PMID:
16406514
13.

Analysis of repetitive element DNA methylation by MethyLight.

Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW.

Nucleic Acids Res. 2005 Dec 2;33(21):6823-36. Print 2005.

14.

Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas.

Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS.

Blood. 2006 Mar 15;107(6):2477-85. Epub 2005 Nov 29.

15.

Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.

Heller G, Fong KM, Girard L, Seidl S, End-Pfützenreuter A, Lang G, Gazdar AF, Minna JD, Zielinski CC, Zöchbauer-Müller S.

Oncogene. 2006 Feb 9;25(6):959-68.

PMID:
16205641
16.

Molecular pathogenesis of diffuse large B-cell lymphoma.

Lossos IS.

J Clin Oncol. 2005 Sep 10;23(26):6351-7. Review.

PMID:
16155019
17.

Epigenetic changes and their clinical relevance in Saudi diffuse large B-cell lymphoma. A molecular and tissue microarray analysis of 100 cases.

Al-Kuraya KS, Siraj AK, Al-Dayel FA, Ezzat AA, Al-Jommah NA, Atizado VL, Narayanappa RN.

Saudi Med J. 2005 Jul;26(7):1099-103.

PMID:
16047061
18.

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A; Lymphoma/Leukemia Molecular Profiling Project.

Blood. 2005 Nov 1;106(9):3183-90. Epub 2005 Jul 26.

19.

Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.

Tagawa H, Suguro M, Tsuzuki S, Matsuo K, Karnan S, Ohshima K, Okamoto M, Morishima Y, Nakamura S, Seto M.

Blood. 2005 Sep 1;106(5):1770-7. Epub 2005 May 10. Erratum in: Blood. 2006 Apr 15;107(8):3052.

20.

Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.

Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K, Ueno M, Takahashi F, Kusano M, Mita H, Yanagihara K, Endo T, Hinoda Y, Tokino T, Imai K.

Clin Cancer Res. 2005 Feb 1;11(3):1021-7.

Supplemental Content

Support Center